hiv-infections

Documents about hiv-infections

• A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV-1 IIIB Env/Gag/Pol Vaccine (TBC-3B)#853572ClinicalTrials.gov
• A Phase I/II Dose Escalation Study of Intradermal gp160 to Evaluate Safety, Delayed Type Hypersensitivity (Skin Test) Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More Than 400 CD4+ Cells#898685ClinicalTrials.gov
• A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines#148587ClinicalTrials.gov
• "It's a very, very thorny issue … ": healthcare providers' experiences, challenges, and insights on HIV status disclosure to children and adolescents living with HIV from across 12 African countries.#281587PubMed
• Pathways of onward HIV disclosure in relationships among young people living with vertically acquired HIV receiving antiretroviral therapy: A qualitative analysis from the BREATHER Plus trial, South Africa.#477142PubMed
• A Placebo-Controlled, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Envelope Proteins of HIV-1 gp160 and gp120 in Children >= 1 Month Old With Asymptomatic HIV Infection#668847ClinicalTrials.gov
• Evaluating Host and Viral Factors Among HIV Infected Former Commercial Blood Donors in Fuyang, Anhui Province, China#803158ClinicalTrials.gov
• Proyecto SOL: A Risk Reduction Intervention for Hispanic Men Who Have Sex With Men (MSM)#840564ClinicalTrials.gov
• Efficacy and Safety of Low-Dose Colchicine on Surrogate Markers of Cardiovascular Events in People Living With HIV Receiving Antiretroviral Therapy#873235ClinicalTrials.gov
• Regimen Switch to Dolutegravir/Lamivudine Fixed Dose Combination From Current Antiretroviral Regimen in HIV-1 Infected and Virologically Suppressed Adults (SALSA)#879235ClinicalTrials.gov
• The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors#883800ClinicalTrials.gov
• Use of a Nutritional Supplement to Treat Diabetic Symptoms in HIV-Infected Adults#900047ClinicalTrials.gov
• People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity#904197ClinicalTrials.gov
• Gender and HIV / AIDS: examining HIV/AIDS communication among Black students in heterosexual relationships at the University of KwaZulu-Natal, Howard College campus.#647673ResearchSpace
• Safety and Effectiveness of Ritonavir Plus Lamivudine Plus Zidovudine in HIV-Infected Pregnant Women and Their Babies#836571ClinicalTrials.gov
• A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis#837779ClinicalTrials.gov
• Stigma in UK health care: a key barrier to reaching zero HIV transmission by 2030.#9858PubMed
• The experiences of clinical research staff during an HIV cure trial with an analytical treatment interruption in Durban, South Africa.#9959PubMed
• Phase I Safety and Immunogenicity Trial of Vaccinia-HIV Envelope Recombinant Vaccine (HIVAC-1e) in Combination With Soluble Recombinant Envelope Vaccine (gp160; VaxSyn)#67680ClinicalTrials.gov
• Coronary Artery Disease and Its Association With Liver Steatosis Among HIV-Infected Persons#311014ClinicalTrials.gov
• Safety of and Immune Response to a DNA Vaccine and a Recombinant HIV-1-MVA Vaccine, Separately and in Combination, in Healthy Adults#325160ClinicalTrials.gov
• A Phase I Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160#381829ClinicalTrials.gov
• Elucidation of early evolution of HIV-1 GroupM in the Congo Basin using computational methods#470009SUNScholar
• Implementation and Delivery of Cabotegravir Long Acting Injection for PrEP in a Community Pharmacy Setting.#801505ClinicalTrials.gov
• The Pharmacokinetics of Zidovudine and Oxazepam Alone and in Combination in the HIV-Infected Patient#805581ClinicalTrials.gov
• TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk#811605ClinicalTrials.gov
• Drug Interaction Study Between Inhaled Beclomethasone and Protease Inhibitors in Healthy Volunteers#828772ClinicalTrials.gov
• Injecting Drug Use Community Intervention Trial#858313ClinicalTrials.gov
• AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIV#868132ClinicalTrials.gov
• The Safety and Effectiveness of Human Monoclonal Antibody, F105, in the Treatment of HIV#886687ClinicalTrials.gov
• Estimation of the Prevalence of HIV, Hepatitis C and Hepatitis B Infection Among Detainees in the Nîmes Administrative Detention Center#905880ClinicalTrials.gov
• Evaluating the Safety and Efficacy of Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load#909495ClinicalTrials.gov
• Extended Follow-Up of the ISS T-003 Trial Volunteers (ISS T-003 EF-UP2020)#226328ClinicalTrials.gov
• The Cheeky Study: A Novel Delivery System for CAB-RPV LA#802113ClinicalTrials.gov
• Integrating Supports to Promote PrEP for Black Adolescents Working With Apps- Atlanta#805458ClinicalTrials.gov
• Australian Hepatitis and Risk Survey in Prisons#810143ClinicalTrials.gov
• DNA Clearance of Uncomplicated Trichomonas Vaginalis Infections in HIV Negative Women#826772ClinicalTrials.gov
• ETE Interventions in the Dental Setting#868975ClinicalTrials.gov
• A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With Fluconazole#869105ClinicalTrials.gov
• A Phase I Multicenter Study of the Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine Given Either Alone or in Combination With IIIB rgp120/HIV-1 Vaccine in Healthy Adult Subjects (NOTE: Original Study Extended ONLY for Patients Previously Enrolled on VEU 009)#887628ClinicalTrials.gov
• Metabolic Liver Disease in Newly Diagnosed People Living With HIV (MASHIV-TR)#802659ClinicalTrials.gov
• Effectiveness of AZT and Nevirapine in Preventing HIV Transmission From Ugandan Mothers to Their Newborns#863517ClinicalTrials.gov
• A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules#143654ClinicalTrials.gov
• A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group#143666ClinicalTrials.gov
• A Multicenter, Randomized, Placebo-Controlled, Double-Blinded, Phase I Trial to Evaluate the Safety and Immunogenicity of Live Recombinant Canarypox ALVAC-HIV vCP205 Combined With GM-CSF in Healthy, HIV-1 Uninfected Volunteers#148557ClinicalTrials.gov
• A Clinical Trial to Evaluate the Safety and Immunogenicity of BG505 MD39.3, BG505 MD39.3 gp151, and BG505 MD39.3 gp151 CD4KO HIV Trimer mRNA Vaccines in Healthy, HIV-uninfected Adult Participants#245587ClinicalTrials.gov
• TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors#824809ClinicalTrials.gov
• A Randomized, Double-blinded, Placebo-controlled, Dose-escalation Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV Envelope Protein BG505 SOSIP.664 gp140 Vaccine, Adjuvanted, in Healthy, HIV-1 Uninfected Adults#904924ClinicalTrials.gov
• Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment#876734ClinicalTrials.gov
• The Pilot Study of Foscarnet Cream in the Treatment of Mucocutaneous Herpes Simplex Virus Infections in Immunocompromised Patients Unresponsive to Acyclovir Treatment#812953ClinicalTrials.gov